According to Gram Research analysis, patients with fatty liver disease face significant barriers to healthy living beyond simple willpower: a 2026 cross-sectional study found that 31% experience anxiety, 16% show depression symptoms, and 20% struggle with binge eating—all of which undermine diet and exercise adherence. More than half (56%) fail to follow a Mediterranean diet, one-third report low activity levels, and 42% drink alcohol weekly despite their diagnosis. These interconnected mental health and behavioral challenges explain why lifestyle change is so difficult for many MASLD patients.

A new study from Canada looked at why people with metabolic dysfunction-associated steatotic liver disease (MASLD)—a condition where fat builds up in the liver—have trouble sticking to healthy habits. Researchers found that these patients face real obstacles: many experience anxiety and depression, struggle with overeating, don’t follow Mediterranean-style diets well, and aren’t active enough. The study shows that treating this liver disease isn’t just about telling people to eat better and exercise more. Doctors need to address mental health issues and eating behaviors too, because these problems make it much harder for patients to make the lifestyle changes that could help their livers heal.

Key Statistics

A 2026 cross-sectional study of Canadian patients with metabolic dysfunction-associated steatotic liver disease found that 31% experienced anxiety symptoms and 16% showed depressive symptoms, both significant barriers to lifestyle change.

According to research reviewed by Gram, 56% of MASLD patients showed poor adherence to a Mediterranean diet and 34% had only moderate adherence, meaning 90% weren’t eating optimally for liver health.

A 2026 Canadian study found that 20% of fatty liver disease patients exhibited moderate to severe binge eating behaviors, and 42% reported weekly alcohol consumption despite their diagnosis.

Research shows that patients with advanced liver scarring from MASLD were significantly older (median 58.4 years), heavier (BMI 36.3), and more likely to have type-2 diabetes compared to those with milder disease.

The Quick Take

  • What they studied: Why patients with fatty liver disease (MASLD) struggle to follow healthy eating and exercise recommendations, and what barriers get in their way.
  • Who participated: Canadian adults diagnosed with MASLD, including those with advanced liver scarring. The study looked at people at one point in time to understand their current habits and challenges.
  • Key finding: More than half of patients weren’t following a healthy Mediterranean diet, one-third weren’t exercising enough, and about 31% had anxiety symptoms while 16% showed signs of depression—all things that make it harder to stick to healthy changes.
  • What it means for you: If you have fatty liver disease, struggling with diet and exercise might not be a personal failure—anxiety, depression, and binge eating are common challenges that deserve treatment alongside liver care. Talk to your doctor about mental health support, not just diet advice.

The Research Details

Researchers in Canada collected information from patients with MASLD at a single point in time, asking them about their eating habits, exercise levels, and mental health. This type of study is called ‘cross-sectional’ because it takes a snapshot of people at one moment, rather than following them over months or years. The researchers used standard questionnaires to measure diet quality (Mediterranean diet score), physical activity levels, anxiety, depression, and eating behaviors like binge eating. They compared patients with advanced liver scarring to those with less severe disease to see if the sicker patients had different lifestyle patterns.

Understanding what barriers patients actually face is crucial for designing better treatment plans. Instead of just telling people ’eat healthier and exercise more,’ doctors can now see that mental health problems and eating disorders are major obstacles. This approach helps create more realistic and compassionate treatment strategies that address the root causes, not just the symptoms.

This study provides a clear snapshot of the Canadian MASLD population, which is valuable because previous research hadn’t specifically looked at lifestyle adherence in this group. However, because it’s a cross-sectional study (one point in time), it can’t prove that anxiety causes poor diet adherence—only that they occur together. The study also relied on people self-reporting their exercise levels, which can be less accurate than objective measurements. The lack of a specific sample size reported is a limitation for understanding how many people were studied.

What the Results Show

The research revealed significant lifestyle challenges among MASLD patients. More than half (56%) showed poor adherence to a Mediterranean diet, while another 34% had only moderate adherence—meaning 90% weren’t eating optimally for liver health. One-third of patients reported low physical activity levels, and 42% drank alcohol weekly despite having liver disease. Mental health emerged as a major barrier: 31% experienced anxiety symptoms and 16% showed depressive symptoms based on standard screening tools. Additionally, 20% of patients exhibited moderate to severe binge eating behaviors, which directly undermines dietary goals. Patients with advanced liver scarring (fibrosis) were older, heavier, and more likely to have diabetes and high blood pressure compared to those with milder disease.

The study found that patients with advanced fibrosis were significantly older (median age 58.4 years versus 45.3 years) and had higher body mass indexes (36.3 versus 31.2). They were also more likely to have type-2 diabetes, high blood pressure, and thyroid disease. Interestingly, most advanced fibrosis patients were of white ethnicity, suggesting possible differences in disease progression or healthcare access across populations. The combination of multiple metabolic problems alongside mental health issues and poor lifestyle adherence paints a picture of patients facing interconnected challenges rather than simple behavioral choices.

This is the first Canadian study specifically examining lifestyle adherence patterns in MASLD patients, filling an important gap in the research. Previous studies have shown that Mediterranean diet and exercise help treat fatty liver disease, but this research explains why many patients struggle to implement these changes. The high rates of anxiety (31%) and depression (16%) align with international research showing mental health problems are common in liver disease, though the specific rates vary by population. The poor Mediterranean diet adherence (56% poor) is consistent with general population studies showing most people don’t follow this eating pattern.

The study captured only one moment in time, so it can’t show whether anxiety causes poor diet adherence or if they’re just coincidentally related. Patients self-reported their exercise levels, which tend to be overestimated compared to actual measured activity. The study didn’t specify exactly how many patients were included, making it harder to judge how representative the findings are. Because it’s a Canadian study, the results may not apply equally to other countries with different healthcare systems or populations. The research also didn’t measure actual liver health improvements, only current lifestyle patterns.

The Bottom Line

If you have MASLD, work with your healthcare team on a multi-pronged approach: (1) Seek evaluation and treatment for anxiety and depression—these are treatable conditions that directly impact your ability to make lifestyle changes (high confidence); (2) Ask about referral to a registered dietitian who can help you gradually improve your diet toward Mediterranean-style eating (high confidence); (3) Start with small, achievable increases in physical activity rather than dramatic changes (high confidence); (4) If you struggle with binge eating, ask for referral to a mental health professional or eating disorder specialist (moderate confidence). Avoid alcohol completely, as it accelerates liver damage (high confidence).

This research is most relevant for people diagnosed with MASLD or fatty liver disease, their family members, and healthcare providers treating liver disease. It’s particularly important for patients who feel frustrated about not being able to stick to lifestyle changes—this study shows that’s often because of treatable mental health conditions, not personal weakness. People with metabolic syndrome, obesity, or type-2 diabetes should also pay attention, as they’re at risk for developing MASLD. Those without liver disease can learn that mental health and eating behaviors are interconnected with physical health.

Changes don’t happen overnight. Expect 4-8 weeks to notice improvements in mood and eating patterns if you address anxiety and depression with professional help. Dietary improvements typically show measurable liver changes within 3-6 months of consistent Mediterranean diet adherence. Physical activity benefits accumulate gradually—you might feel more energetic within 2-3 weeks but need 8-12 weeks for significant fitness improvements. Liver scarring reversal takes longer, typically 6-12 months of sustained lifestyle changes. Be patient and celebrate small wins.

Frequently Asked Questions

Why do people with fatty liver disease struggle to exercise and eat healthy?

A 2026 study found that anxiety (31% of patients), depression (16%), and binge eating (20%) are common in MASLD and directly interfere with lifestyle changes. These aren’t personal failures—they’re treatable medical conditions that need professional support alongside diet and exercise advice.

What percentage of fatty liver disease patients follow a Mediterranean diet?

Only 10% of MASLD patients in a 2026 Canadian study had good Mediterranean diet adherence. 56% showed poor adherence and 34% had moderate adherence, indicating most patients need dietary support and education.

Is depression common in people with metabolic fatty liver disease?

Yes, research shows 16% of MASLD patients have depressive symptoms and 31% experience anxiety. These mental health conditions are significantly more common in fatty liver disease than the general population and require treatment.

Can treating anxiety and depression help improve fatty liver disease outcomes?

While this study didn’t measure liver improvements, research shows that anxiety and depression directly prevent people from following healthy diets and exercise routines. Treating mental health removes a major barrier to the lifestyle changes that improve liver health.

What’s the connection between binge eating and fatty liver disease?

A 2026 study found 20% of MASLD patients have moderate to severe binge eating behaviors. Binge eating directly undermines dietary goals and contributes to weight gain, both harmful for liver health. This requires specialized eating disorder treatment, not just willpower.

Want to Apply This Research?

  • Track three daily metrics: (1) Mood score (1-10 scale), (2) Mediterranean diet adherence (count servings of vegetables, whole grains, olive oil, fish), and (3) Minutes of physical activity. This captures the three main barriers identified in the research.
  • Use the app to set one small, specific goal per week rather than overhauling everything at once. Example: ‘Add one extra vegetable serving to dinner’ or ‘Take a 10-minute walk after lunch.’ Link these to mood tracking to help you see the connection between activity and mental health improvements.
  • Create a weekly review ritual where you look at patterns across all three metrics. If mood is low, prioritize mental health support before pushing harder on diet/exercise. If binge eating episodes spike, that’s a signal to reach out to your healthcare provider rather than increasing restrictions. Use the app’s trend view to celebrate improvements over 4-week periods rather than daily fluctuations.

This research describes patterns in fatty liver disease patients but does not provide medical advice. If you have been diagnosed with MASLD or fatty liver disease, consult your healthcare provider before making changes to diet, exercise, or medications. Mental health symptoms (anxiety, depression, binge eating) require professional evaluation and treatment. This study is observational and cannot prove that one factor causes another—only that they occur together. Results are from a Canadian population and may not apply equally to other regions or ethnic groups.

This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.

Source: Lifestyle Adherence and Health Behaviours in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: A Cross-Sectional Study.The British journal of nutrition (2026). PubMed 41937251 | DOI